NCT02978222 2022-12-15Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian CancerMarker Therapeutics, Inc.Phase 2 Terminated120 enrolled 12 charts
NCT02576561 2017-10-25Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSILTHEVAX Genetics VaccinePhase 2 Unknown10 enrolled